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Abstract 
Recently, one of the first fungal-
expressed, deglycosylating, Endo-β-N-
acetylglucosaminidases was found in the 
extracellular medium of soft-rot 
ascomycete Hypocrea jecorina (a.k.a. 
Trichoderma reesei) belonging to  
glycoside hydrolase family 18 (GH18). It 
was named Endo-T and has been shown 
to possess similar substrate specificities 
as Endo-H from Streptomyces plicatus, a 
deglycosylating enzyme, frequently used 
in the field of glycoproteomics. In this 
study an oligomannosidic N-glycan was 
introduced in the active site of 
crystallized Endo-T under acidic pH 
conditions below pH 3. The ligand-
containing crystal diffracted on a 
synchrotron x-ray source to a resolution 
of 1.65Å. The resulting Endo-T 
structure was found to contain a bound 
ligand consisting of a hydrolyzed 
Manα1-6(Manα1-3)Manα1-6Manβ1-
4GlcNAc N-glycan, lacking the 
aspargine linked N-acetylglucosamine 
residue of N-glycans. Furthermore, 
electron density was missing for several 
of the distal glycone mannose residues. 
The anomeric carbon of the distal N-
acetylglucosamine residue was found to 
be positioned 6.88Å from the proposed 
catalytic amino acid residue, Glu131, 
indicating a descending motion during 
hydrolysis. An unidentified electron 
density was found after the last 
structure refinement, apparently shaped 
as a furanose ring, next to the N-glycan 
ligand in the active site around unit 8 of 
the (β/α)8-barrel. Proximal substrate 
positioning and the loop-structure of 
Endo-T suggests aglycone docking 
centered over (β/α)8-barrel unit 5. 
 
 
Introduction 
 
Glycosylation 
Glycosylation is the covalent attachment of 
carbohydrates to non-carbohydrate organic 
compounds, e.g. proteins and lipids, 
catalyzed by glycosyltransferases1, 2. The 
biological functions of the 
oligosaccharides attached are many and 
diverse spanning from sterical protection 
from degrading enzymes and structure 
stabilization to hormonal, cell-cell and 
cell-matrix interactions3. The reason for 
the diverse range of biological functions of 
the carbohydrates is a wide variety of 
structural combinations. There are, for 
instance, 1012 different isomers of a 
hexasaccharide consisting of only six 
monosaccharide residues4.  
 
N-linked glycoproteins 
Glycoproteins are a common type of 
glycoconjugates where the glycan is 
covalently attached to the polypeptide 
backbone of a protein in an O-linked or N-
linked matter. The O-linked glycans are 
attached to the hydroxyl group of the 
amino acids serine and/or threonine while 
the N-linked glycans are bound to the 
amide group of the amino acid aspargine5. 
N-glycans are most often involved in 
interacting with the environment as a 
recognition signal and all of these glycans 
contain a specific pentasaccharide core: 
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-
4GlcNAc, where the two N-
acetylglucosamines are located at the 
reducing terminal attached to the 
aspargine5. The differences starts with the 
glycan residues linked further onto the 
pentasaccharide core resulting in three 
different types of N-glycans: Complex, 
high mannose and hybrid N-glycan 
chains5. The complex types of N-glycans 
contain no additional mannose residues but 
the three mannose residues included in the 
pentasaccharide core and instead contain 
other glycan residues linked to the three 
mannose and the proximal N-
acetylglucosamine residues of the core5. 
The high mannose type N-glycans have 
only mannose residues attached, purely to 
the two distal mannose residues of the 
pentasaccharide core. The hybrid group 
contains both characteristics of complex 
and high mannose type N-glycans5. 
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Figure 1. Pentasaccharide core of N-linked 
glycans. The pentasaccharide core consisting of a 
Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc 
molecule attached to an aspargine residue on the 
aglycone protein. Arrows indicate the possible 
extensions of glycan residues (dotted arrows 
indicate single monosaccharide extensions only 
found in complex and hybrid N-glycans)5.  
 
 
Deglycosylation 
Deglycosylation is the process of removing 
sugar residues from glycosylated organic 
compounds by glycosidic bond hydrolysis. 
The glycosidic bond, which links the 
carbohydrate residues to other 
carbohydrates or other non-carbohydrate 
organic compounds, is cleaved in a 
hydrolytic reaction comprising two 
essential catalytic residues: a proton donor 
and a nucleophile/base, most often aspartic 
acid and/or glutamic acid amino acid 
residues in the active site of the 
deglycosylating enzyme6, 7. Different 
positions of the base residue with regard to 
the carbohydrate anomeric carbon facilitate 
either retention or inversion of the 
anomeric configuration after hydrolysis. 
The retaining mechanism is characterized 
by a short distance between the base 
residue and the anomeric carbon while the 
inverting mechanism often demonstrates a 
larger distance between the two (~4.5 Å 
longer) to provide room for the attacking 
water molecule creating the inverted 
anomeric configuration8. 
Glycoside hydrolases – classification 
systems 
Glycoside hydrolases (EC 3.2.1.x) are the 
enzymes responsible for degrading the 
complex and diverse carbohydrate 
structures on glycosylated proteins. As 
carbohydrates are both structurally 
complex and involved in a multitude of 
biological functions there is a huge number 
of various glycoside hydrolases expressed 
by all realms of life. The IUB 
(International Union of Biochemistry) 
Enzyme Nomenclature (1984) was the first 
established classification model for 
enzymes based on the biochemical reaction 
performed by the enzyme and on its 
specificity towards substrates. This 
classification system is a good way of 
avoiding redundant inventions of names 
for the same enzyme and creating a 
universal system. A problem with the 
system is that it does not take into account 
the structural properties of the enzymes as 
the reaction and substrate-specificity often 
does not reflect the three dimensional 
structure of the protein which is a very 
common phenomena amongst the 
glycoside hydrolases. Another problem is 
that the classification is based on a “one 
kind of enzyme, one kind of substrate” 
way of thinking even though many 
enzymes demonstrate a wide specificity 
towards several substrates9. As it had 
previously been shown that structural 
properties were directly related to the 
amino acid sequence of proteins10 a new 
classification system was created which is 
based on peptide sequence similarities of 
carbohydrate-processing enzymes9, 11-15. 
This system does not only expose 
structural and evolutionary relationships 
between the different enzymes but does 
also provide information about the reaction 
mechanisms as the IUB system9. The 
carbohydrate-processing enzymes have 
been classified into numerous sequence-
related families, where the glycoside 
hydrolases currently include 118 families 
(CAZy)16, and these families are frequently 
updated as sequences and three-
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dimensional structures of additional 
enzymes are being solved continuously. A 
database have been established which lists 
these families of carbohydrate-processing 
enzymes, called CAZy (Carbohydrate 
Active Enzymes, http://www.cazy.org/)16. 
 
Endo-T 
 
Endo-β-N-acetylglucosaminidases 
Endo-β-N-acetylglucosaminidases (IUB: 
EC 3.2.1.96, ENGases, Endo:s) are a group 
of endoglycoside hydrolases which 
catalyze the hydrolysis of the glycosidic 
bond between the two proximal N-
acetylglucosamines linked to the aspargine 
in N-linked glycans leaving one N-
acetylglucosamine residue with the 
aglycone (aspargine part) and the other 
becomes the reducing end of the detached 
N-glycan (glycone)21, 45. A two-step 
retaining substrate assisted mechanism is 
believed to be utilized (Figure 2). In the 
first step, the acetamido group of the non-
asparagine bound N-acetylglucosamine 
residue of the substrate makes a 
nucleophilic attack on the anomeric carbon 
and forms an oxazoline intermediate. In the 
second step, the attack of a water molecule 
on the anomeric carbon of the substrate 
completes the cycle of hydrolysis20, 52-56.  
 
 
Figure 2. Two-step substrate assisted hydrolysis 
(www.CAZypedia.org). The formation of an 
oxazoline intermediate by the non-aspargine linked 
N-acetylglucosamine residue of the substrate, 
assisting in a two-step hydrolysis of an N-glycan 
substrate together with a proton donor residue and a 
stabilizing residue20, 52-56. 
 
A carboxylate of an amino acid residue is 
believed to stabilize the oxazoline 
intermediate during the transition states of 
the reaction and the catalytic proton 
donation is believed to be performed by a 
glutamic acid residue16. Members of this 
group of enzymes are found in family 18 
(GH18) and 85 (GH85) of glycoside 
hydrolases16. Four members of Endo-β-N-
acetylglucosaminidases are present in 
family GH85 expressed by both eukaryotes 
and prokaryotes: Endo-M from Mucor 
hiemalis17, Endo-CE from C. elegans18, 
Endo-A from Arthrobacter 
protophormiae19 and Endo-D from 
Streptococcus pneumoniae20. GH18 are 
related to chitin-degrading chitinases and 
contained until recently Endo-β-N-
acetylglucosaminidases solely expressed 
by prokaryotes including Endo-H from 
Streptomyces plicatus21, Endo-F1, F2, F3 
from Elizabethkingia meningoseptica22 and 
Endo-S from Streptococcus pyogenes23. 
Recently, however, new members of GH 
family 18 have been discovered to be 
expressed by both ascomycete and 
basidiomycete fungi comprising Endo-T 
from Hypocrea jecorina and its 
homologous proteins24 and Endo-FV from 
Flammulina velutipes25 respectively.  
 
An endo-β-N-acetylglucosaminidase found 
in H. jecorina 
The Endo-β-N-acetylglucosaminidase that 
recently was found to be expressed and 
secreted by the mesophilic soft-rot 
ascomycete Hypocrea jecorina, formerly 
known as Trichoderma reesei (hence the 
“T” in Endo-T), by Stals and her 
colleagues has been shown to enzymaticly 
process N-linked oligomannosidic, 
phosphorylated and hypermannosylated 
glycoproteins24. Endo-T has low sequence 
homology to other protein members of 
GH18 family but has similar substrate-
specificities as two other GH family 18 
group members, Endo-H and Endo-F121, 22, 
24
. Endo-T consists of 287 amino acids 
(after N- and C-terminal processing; 
Ingeborg Stals, Ghent University, Belgium, 
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personal communication). It has a pI of 
4.33 (ProtParam, ExPASy Proteomics 
Server) and a mass of approximately 30 
kDa (according to SDS-PAGE analysis but 
with a theoretical mass of 31.755kDa) 
depending on the grade of N- and C-
terminal processing (Ingeborg Stals, Ghent 
University, Belgium, personal 
communication). The homologue Endo-H 
from Streptomyces plicatus, found 1974 by 
Tarentino and his colleagues21 is nowadays 
frequently used as a deglycosylation 
reagent in glycoprotein research to study 
the structure and functions of N-linked 
carbohydrates26, 27. Another area of usage 
is the removal of oligosaccharides from 
glycosylated proteins to enable 
biochemical characterization and 
crystallography studies of the aglycone 
protein (personal communication). As 
Endo-H is fairly expensive to purchase at 
the moment as it is patented and sold 
extensively overpriced by Roche 
Diagnostics, Endo-T has emerged as a 
good candidate substitute since it has 
similar substrate specificities as Endo-H 
and can be produced at a high rate due to 
the high enzyme-producing properties of 
Hypocrea jecorina. Hence, Endo-T has the 
potential of significantly reducing the cost 
for this type of enzymatic deglycosylation 
treatment worldwide. 
 
Structure biology of Endo-T 
The structure of Endo-T expressed by 
Hypocrea jecorina was solved by Dr. 
Saeid Karkehabadi and Dr. Mats Sandgren 
at the department of molecular biology, 
Swedish University of Agricultural 
Sciences, Uppsala, Sweden (personal 
communication) with help from a former 
bachelor project student Mia C. Hertzberg, 
to a resolution of 1.3 Å by multiple 
anomalous dispersion (MAD) methods, 
using bound zinc molecules for the 
phasing28(Figure 3). The fold of the protein 
is the common TIM (β/α)8-barrel shared by 
the ENGases but with some unique folding 
differences to the Endo-β-N-
acetylglucosaminidase and chitinase 
 
 
 
 
 
Figure 3. Cartoon representation of the three-
dimensional structure of Endo-β-N-
acetylglucosaminidase T from Hypocrea 
jecorina. The (β/α)8-barrel structure is colored from 
blue to red starting at the N-terminous of the 
enzyme. The eight α-helix (A) and β-barrel (B) 
units of the (β/α)8-barrel are labeled in the figure. 
 
 
structures of GH family 18 (Saeid 
Karkehabadi et al., personal 
communication). The (β/α)8-barrel consist 
of eight β-strand/loop/α-helix units (Figure 
3) where the catalytic site is positioned on 
top of the core of the barrel-structure 
(Saeid Karkehabadi et al., personal 
communication). Aspartic acid 129 and 
glutamic acid 131 of Endo-T are found to 
be conserved amino acids within GH 
family 18, and these amino acids are 
thought to be catalytic residues as the 
mutational substitution of these amino 
acids in Endo-H resulted in loss of 
hydrolytic activity29. Tyrosine 195 and 
tryptophan 259 are also believed to have 
important roles where Tyr 195 has been 
shown to be important in homologue 
enzymes, aiding the substrate binding30 
and Trp259 is believed to stabilize the 
enzyme-substrate interaction28. Endo-T has 
been shown to be glycosylated with a 
single N-acetylglucosamine residue on 
aspargine 70 and 240 28. 
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X-ray crystallography 
 
Crystallization 
Crystals are solidified ordered aggregates 
of molecules and are formed under 
supersaturation, i.e. a non-equilibrium 
state31. At a non-equilibrium state, a 
solution contains more of a dissolved 
molecule than could be dissolved under 
normal conditions and therefore results in 
solidification of that molecule until the 
equilibrium concentration of saturation is 
reached31. The formation of crystals starts 
with nucleation, when the molecules 
diverge from the single molecule solution 
state into ordered multimolecular 
aggregates31. Nucleation is followed by 
crystal growth, where the molecules are 
obliged to join the multimolecular 
nucleations instead of roaming free in the 
solution31. Crystallization of proteins is a 
crucial step in solving their three-
dimensional structure and is utilized 
extensively in the fields of biology. A 
problem with protein crystallization is that 
macromolecules can under supersaturation, 
except from forming crystals, also form 
disordered aggregates which are useless31. 
The art of generating protein crystals 
involves many different parameters 
including protein sample purity, pH, 
temperature, precipitants and buffers. The 
purity of the protein sample used for 
crystallization experiments is critical as 
protein crystals are aggregates with 
perfectly ordered identical protein units 
and are extremely sensitive to foreign 
proteins or structurally deviating protein 
variants31. Precipitants are compounds 
used in the crystal solution to change the 
interactions between the protein and the 
surrounding solvent to promote protein 
precipitation out of the solution into 
crystals31. There are different types of 
precipitants including salts, organic 
solvents and polymers, where the salts 
ammonium sulphate and sodium chloride 
and the polymer polyethylene glycol 
(PEG) are the most commonly used. The 
methods used for protein crystallization 
includes the most frequently used vapor 
diffusion method and other techniques 
such as dialysis, the batch method and free 
interface diffusion31. In the vapor diffusion 
method a droplet of typically 1-10µl highly 
concentrated protein sample is placed on a 
glass lid or pedestal and mixed with equal 
amounts of crystallization solution 
containing buffer and precipitants31. The 
drop is then placed in a sealed environment 
containing a well filled with 500-1000µl 
crystallization solution. As the 
concentration of the crystallization solution 
components is lower in the droplet 
compared to the well solution, vapor 
diffusion brings the environment to 
equilibrium by supersaturation of the 
droplet and hopefully crystal formation31. 
 
X-ray diffraction 
Structure determination from protein 
crystals by X-ray diffraction is possible 
because of the ability of electrons in the 
crystal to scatter X-rays. When an X-ray 
beam hits the electrons of a protein crystal 
it becomes scattered and creates a specific 
diffraction pattern, the combinatorial 
diffraction from probably millions of 
electron induced diffractions32. This 
pattern of scattered X-ray can be reversibly 
calculated back to the positions of its 
scattering sources, the electrons of the 
protein crystal and by retracing the 
positions of the protein electrons the 
spatial occupancy of all atoms in the 
protein can be determined, i.e. the protein 
electron density map32. The crystal 
construct is also vital for protein structure 
determination. The diffraction signals from 
the electrons of a single protein molecule 
are undetectable32. The ordered crystal 
lattice organization of repeated protein 
molecules creates an amplification of the 
diffraction signals and enables diffraction 
pattern detection32. However, first of all 
the protein of interest must be crystallized 
into good quality protein crystals. The 
protein crystals must then be flash frozen 
in liquid nitrogen (100 K) to prevent X-
ray-induced radiation damage of the 
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protein crystal in the x-ray beam. The flash 
freezing itself can cause crystal-damage by 
crystalline ice formation31. This is however 
prevented by coating the crystals with 
cryoprotectant solution which has a lower 
concentration of ice-forming water 
molecules31. The protein crystal is 
subsequently transferred onto a goniometer 
on an X-ray machine which can accurately 
position and rotate the crystal in relation to 
the X-ray beam. The protein crystal is then 
irradiated with an X-ray beam originating 
from a synchrotron or home lab generator 
X-ray source. The pattern of the diffracted 
X-ray beam was formerly detected by an 
X-ray film but is nowadays detected by 
modern image plates and area detectors32. 
In order to collect a complete diffraction 
data set, containing information about the 
density of almost all electrons of the 
protein molecule, the crystal has to diffract 
X-ray in multiple rotation angles32. The 
three-dimensional electron density map of 
the crystal unit cell is then calculated from 
the intensity and positioning of the 
diffraction pattern spots of the crystal in 
different orientations32. The important 
information needed to determine the 
protein structure is obtained from the 
intensity of the diffraction spots which are 
related to the amplitude of the 
electromagnetic wave of the diffracted X-
ray32. To be able to calculate the electron 
density map both amplitudes and phase 
angles of the electromagnetic waves must 
be known32. While the amplitude can be 
calculated from the spot intensity, the 
phase angles can not be extracted from the 
collected X-ray diffraction dataset32. This 
problem, known as the phase problem is 
solved by the use of three existing 
methods: 1) The isomorphous replacement 
method32 where diffraction pattern 
intensity differences of protein-linked 
heavy atoms are used as known factors to 
determine the phase angles, 2) The 
anomalous scattering methods32 which 
utilize the deviating X-ray scattering by 
electrons in the inner shells of the electron 
cloud of native heavy atoms of the protein 
at certain wavelengths for phase angle 
determination or 3) The molecular 
replacement method32 where the phase 
information from the solved structure of a 
similar protein is combined with the 
diffraction spot intensities of the unsolved 
structure to obtain the electron density 
map. The molecular replacement method is 
mostly applied for solving structures of 
ligand-bound or mutated proteins where 
the apo- or wild type structure is already 
solved. After obtaining an electron density 
map, different computer programs are used 
to build the protein molecule that both fits 
well inside of the electron density and fits 
the correct geometry of a protein molecule, 
such as bond angles and bond lengths32. 
The protein structure model will be refined 
until the researcher determines the 
structure model to be of acceptable quality. 
The quality of the crystal, i.e. the 
concordance between the diffraction data 
and the structure model, can be 
demonstrated by the R and Rfree factor32. 
 
High performance an-ion exchange 
chromatography with pulsed 
amperometric detection (HPAEC-PAD) 
A high performance an-ion exchange 
(HPAE) method was developed due to the 
lack of simple and effective alternatives for 
carbohydrate-analyzing chromatography 
methods33. Together with its pulsed 
amperometric detection (PAD)33 it can 
separate and quantify extremely small 
amounts in the order of picomole 
carbohydrate in a sample, while at the 
same time being highly tolerant against 
sample solution impurities. Neutral 
carbohydrates are actually very weak acids 
with pKa values between 12 and 14 and 
this is exploited in HPAE 
chromatography33. A strong an-ion 
exchange stationary phase is used at 
extremely high pH to ionize the 
carbohydrates and enable a highly 
discriminating separation by charge33. 
Because of the high pH, neutral and 
positively charged compounds are 
conveniently eluted at or close to the void 
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volume of the column33. The column 
material of these anion exchangers consist 
of highly pH stable (0-14), robust, 
polymeric, nonporous micro-beads33. For 
reduced sugars however, a macroporous 
polymeric resin is used which has 45 times 
stronger an-ion strength to be able to bind 
these weakly anionic molecules 
effectively33. The pulsed amperometric 
detection is an extremely sensitive 
detection-method for carbohydrates as it 
can distinguish sugar-sample amounts as 
low as 10 picomoles from the background 
noise33. This method of detection is 
characterized by repeated sequences of 
three different oxidation potentials (P1-
3)33. Firstly, the eluted carbohydrates are 
detected via oxidation of the carbohydrates 
(P1) at the surface of a gold electrode33 
creating an electric current that is 
measured by the detector. During the 
carbohydrate oxidation, poisonous 
products are formed at the gold surface33 
which is removed by raising the oxidation 
potential resulting in an oxidation of the 
gold electrode (P2). Finally the gold oxide 
is reduced back to gold by lowering the 
potential (P3) and then another oxidation-
sequence can start33. The measured 
amounts of oxidized compounds (mainly 
sugar compounds) are collected as data 
files. These data files can then be used by 
certain computer programs for quantitative 
and purity analysis of the characterized 
carbohydrate containing sample33. 
 
Ligand-bound Endo-T structure 
The major aim of this independent master 
project was to crystallize and solve the 
structure of H. jecorina Endo-β-N-
acetylglucosaminidase-T with a ligand 
bound in the active site of the enzyme. A 
bound ligand provides vital information 
about enzyme-substrate interactions 
including interactions with the glycone part 
of the ligand as well as the aglycone 
(carbohydrate-protein) region. The glycone 
interactions contain mechanistic 
information regarding the residues in close 
proximity to the active site, and the 
binding-preferences concerning the diverse 
structure of the distal complex of 
oligosaccharide residues. The aglycone 
region interactions include the area around 
the two proximal N-acetylglucosamines 
linked to the aspargine and the amino acid 
interactions between the 
glycopeptide/glycoprotein and Endo-T. 
The exploration of these interactions will 
facilitate the understanding of the 
biological role of ENGases and enable 
future designs of glycoside hydrolases with 
desirable properties. In this study attempts 
were made to crystallize Endo-T with a 
ligand in the active site via enzyme 
inactivation by either extreme pH 
conditions or the design of inactivated 
Endo-T mutants. The selection of 
inactivated H. jecorina Endo-T mutants 
failed to give rise to healthy mutant H. 
jecorina clones with acquired Endo-T 
overexpression. However, Endo-T ligand 
complex crystals, using wild type enzyme, 
were produced under extreme pH-
conditions i.e. pH 2.4-3.0, and these 
crystals were used for ligand complex 
structure determination. The ligand 
comprises a processed and incomplete 
Manα1-6(Manα1-3)Manα1-6Manβ1-
4GlcNAc N-glycan ligand. In spite of the 
low pH in which the crystals were formed, 
inspection of the electron density map 
clearly showed that Endo-T was not 
completely inactivated since the substrate 
was processed. Electron density for a 
furanose ring was also detected in the 
active site of the ligand-bound Endo-T. 
 
Materials and methods 
 
Ligand preparation and analysis 
 
Preparation of (GlcNac)2-Man5-9  
N-glycans from RNase B 
The N-glycans were generally prepared as 
previously described34. 50 mg/ml of 
Ribonuclease B (RNase B, Sigma-
Aldrich®) was dissolved in denaturing 
solution (1% SDS + 0.5M β-
mercaptoethanol + 0.1M EDTA) and 
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incubated for 30 min at room temperature. 
The RNase B solution was then diluted in 
178mM phosphate buffer (pH 8.6), boiled 
for 5 min at 100ºC and subsequently 
cooled down to room temperature. After 
addition of 0.75% triton X-100, the 
solution was incubated with 10 units of 
PNGase F overnight at 37ºC. On the 
following day the protein solution was 
spun down (15 min at 13000xg) and the 
remaining protein in the supernatant was 
precipitated with pre-cooled 4.3M ethanol 
for 1 hour at 4ºC. After another 
centrifugation of protein (15 min at 
13000xg) the sugar of the supernatant was 
precipitated with pre-cooled 2.7M acetone 
for 10 min at -20ºC. The sugar was then 
spun down (15 min at 13000xg) and the 
pellet was resuspended in 1 ml water. The 
N-glycan sample was subsequently further 
purified with a carbograph column 
(AlltechTM Extract CleanTM SPE Carbo 
150mg/4ml) which was regenerated with 2 
ml 15.3M CH3CN+0.135M trifluoroacetic 
acid and rinsed with 3 column volumes 
water before the loading of the N-glycan 
sample. The column was then washed with 
5 ml water whereafter the bound sugars 
were eluted with 2 ml 4.8M CH3CN. The 
fractions of the loading, washing and 
elution step were collected separately and 
analyzed with high performance an-ion 
exchange chromatography with pulsed 
amperometric detection (HPAEC-PAD; 
ICS-3000, Dionex). The elution-fraction 
sample was dried and resuspended in 100 
µl water to create a highly concentrated 
ligand-sample.  
 
Preparation of Asn-(GlcNac)2-Man5-9 
glycoaspargine from RNase B 
16.7 mg/ml of RNase B (Sigma-Aldrich®) 
was dissolved in 200mM phosphate buffer 
(pH 7.0) and incubated with 11.3 mg/ml 
pronase (protease type XIV from S. 
griseus, Sigma-Aldrich®) overnight or for 
4 days (for increased hydrolysis) at 37ºC. 
After the proteins of the solution were 
pelleted (20 min at 5000xg), the 
glycoaspargines of the supernatant were 
precipitated with pre-cooled 2.7M acetone 
for 10 min at -20ºC. The precipitate was 
subsequently spun down (20 min at 
5000xg) and the pellet was resuspended in 
1 ml water. The glycoaspargine sample 
was then further purified with a carbograph 
column (AlltechTM Extract CleanTM SPE 
Carbo 150mg/4ml), analyzed with 
HPAEC-PAD (ICS-3000, Dionex) and 
concentrated as described above 
(“Preparation of (GlcNac)2-Man5-9 N-
glycans from RNase B”). 
 
Transformation experiment 
Transformation of the mutant constructs 
into Hypocrea jecorina was performed as 
previously described by Penttilä et. al.35. 
The H. jecorina Endo-T knockout strain 
RLP37 (Genencor) was transformed with 
Trichoderma expression vector pTrex3g 
constructs containing the amdS selection 
marker and the mutant sequence of the 
Endo-T gene variants D129A, Q193A, 
E131A and Y195A. 
 
Clone selection process 
Grown protoplast H. jecorina Endo-T 
knockout clones (RLP37 strain, Genencor) 
transformed with different amounts of 
plasmid DNA coding for the four different 
catalytically mutated variants of Endo-T 
(D129A, Q193A, E131A and Y195A) 
were picked with toothpicks, plated on 
sterile 2% glucose amdS selection plates 
(111mM glucose + 110mM KH2PO4 + 
10mM acetamide + 10mM CsCl + 
2.43mM MgSO4*7H2O + 4.08mM 
CaCl2*2H2O + 2.28mM citric acid + 
1.80mM FeSO4*7H2O + 139µM 
ZnSO4*7H2O + 32.0µM CuSO4*5H2O + 
20.7µM MnSO4*H2O + 32.3µM H3BO3 + 
20g/L agar) and grown at 28ºC. Healthy 
growing clones from these plates were re-
plated as above for a second round of 
amdS-based selection. The healthy 
growing clones from the second amdS-
base selection round were grown in sterile 
5 ml cultures with liquid 1.6% lactose 
defined media (46.7mM lactose + 2.78mM 
(NH4)2SO4 + 100mM KH2PO4 + 4.06mM 
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MgSO4*7H2O + 6.85mM CaCl2*6H2O + 
9g/L casamino acids + 2.28mM citric acid 
+ 1.80mM FeSO4*7H2O + 139µM 
ZnSO4*7H2O + 32.0µM CuSO4*5H2O + 
20.7µM MnSO4*H2O + 32.3µM H3BO3) 
which were going to be screened for the 
expressed amounts of Endo-T with SDS-
PAGE analysis (GE Phast 8-25% gradient 
gel, GE Healthcare). 
 
H. jecorina growth cultures 
A healthy growing clone from three of the 
four Endo-T mutant H. jecorina variants 
(D129A, Q193A and Y195A) and the 
Endo-T knock out H. jecorina were 
cultured in sterile 50 ml 2% glucose 
minimal media pre-cultures (111mM 
glucose + 27.8mM (NH4)2SO4 + 5.41mM 
CaCl2 + 4.98mM MgSO4 + 110mM 
KH2PO4 + 9.93µM MnSO4 + 18.0µM 
FeSO4*7H2O + 15.4µM CoCl2 + 9.29µM 
ZnSO4) and subsequently in sterile 300 ml 
2% lactose minimal media induction 
cultures (58.4mM lactose + 27.8mM 
(NH4)2SO4 + 5.41mM CaCl2 + 4.98mM 
MgSO4 + 110mM KH2PO4 + 9.93µM 
MnSO4 + 18.0µM FeSO4*7H2O + 15.4µM 
CoCl2 + 9.29µM ZnSO4), both with 
shaking at 28ºC. Culture medium samples 
from each culture were checked for 
presence of Endo-T with SDS-PAGE 
analysis using 12% manually produced 
gels (Separating gel: 12% 
acrylamide:bisacrylamide 
(AA:bisAA)(37.5:1) + 375mM Tris-HCl 
pH 8.8 + 21.9mM ammonium persulphate 
(APS) + 17.2mM 
Tetramethylethylenediamine (TEMED); 
Stacking gel: 4% AA:bisAA(37.5:1) + 
625mM Tris-HCl pH 6.8 + 43.8mM APS + 
34.4mM TEMED). The samples and a low 
molecular weight marker (GE Healthcare) 
were mixed with sodium dodecyl sulfate 
(SDS)/dye sample buffer and heated 5 min 
at 100ºC before being loaded on the gel. 
The gel was then run in the electrophoresis 
device (Bio-Rad) for about 50 min at 200V 
and subsequently developed with 
Coomassie brilliant blue R-250 (Bio-Rad). 
 
Endo-T purification 
 
Avicel adsorption 
300 ml extracellular medium from each of 
the four induction cultures, containing 
three Endo-T mutant H. jecorina clones 
(D129A, Q193A and Y195A) and an 
Endo-T knock out H. jecorina strain, were 
harvested and the fungal mycelia were 
removed by büchner vacuum filtration. 
After concentrating the filtrates by 
ultrafiltration at 2 bar pressure in stirred 
cells (Amicon, Millipore) using 10 kDa 
NWCO polyethersulfone membranes 
(Biomax-10, Millipore) equal amounts of 
100mM sodium acetate (pH 5.0) and 20g 
of Avicel were added followed by one hour 
incubation with shaking at room 
temperature. The avicel-cellulase 
aggregates were subsequently spun down 
(30 min at 3000xg) and the supernatants 
with the unbound proteins were 
concentrated with the previously 
mentioned ultrafiltration method (“Avicel 
adsorption”).  
 
SDS-PAGE analysis of Avicel purified 
culture filtrate 
SDS-PAGE analysis was then performed 
with 15% gels to check for the presence of 
bands corresponding to the size of Endo-T 
in the three Endo-T mutant H. jecorina 
variant (D129A, Q193A and Y195A) 
protein expression cultures. The gel was 
run and stained as described above (“H. 
jecorina growth cultures”) but made with 
different gel ingredients: Separating gel: 
15% AA:bisAA(30:1) + 7.01M glycerol + 
375mM Tris-HCl pH 8.8 + 0.1% SDS + 
43.8mM APS + 8.6mM TEMED; Stacking 
gel: 4% AA:bisAA(30:1) + 125mM Tris-
HCl pH 6.8 + 0.1% SDS + 21.9mM APS + 
3.44mM TEMED. The bands 
corresponding to the size of Endo-T were 
analyzed and identified with mass 
spectrometry (Ultraflex MALDI 
TOF/TOF, Bruker Daltonics) by Åke 
Engström at the Department of medical 
biochemistry and microbiology, 
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Biomedical centre, Uppsala, Sweden 
(personal communications). 
 
MonoQ an-ion exchange chromatography 
The Avicel-purified supernatant of the 
mutant with verified Endo-T expression 
(D129A) was buffer exchanged with 
20mM Bis-Tris buffer (pH 6.5) using 
Vivaspin 20 concentrators (Sartorius 
Stedim Biotech) to reduce the conductivity 
to 1.5mS and titrated to pH 6.5. Endo-T 
was then purified by an-ion exchange 
chromatography (MonoQ 10/100 GL, GE 
Healthcare) at 4ºC using an ÄKTA 
ExplorerTM 100 system (GE Healthcare). 
The MonoQ column was after equilibration 
with 20mM Bis-Tris buffer (pH 6.5) 
loaded with the Endo-T sample whereafter 
unbound proteins where washed away with 
20mM Bis-Tris buffer (pH 6.5). Bound 
proteins were eluted with a linear gradient 
of 0-1M NaCl in 20mM Bis-Tris buffer 
(pH 6.5). The peak fractions containing 
Endo-T were identified with SDS-PAGE 
(15% manually produced gels described 
above in “SDS-PAGE analysis of Avicel 
purified culture filtrate”) and pooled.  
 
Superdex 200 size-exclusion 
chromatography 
The pooled Endo-T peak fractions were 
concentrated to less than 2 ml (Vivaspin 
20, Sartorius Stedim Biotech) and 
subsequently further purified by size-
exclusion chromatography (HiLoadTM 
16/60 Superdex 200TM, GE Healthcare) 
using an ÄKTA ExplorerTM 100 system 
(GE Healthcare). The superdex 200 
column was after equilibration with 20mM 
NaAc (pH 5.0) loaded with the 
concentrated Endo-T sample and eluted 
with a constant flow of 20mM NaAc (pH 
5.0). The peak fractions containing Endo-T 
were identified with SDS-PAGE (15% 
manually produced gels described above in 
“SDS-PAGE analysis of Avicel purified 
culture filtrate”) and verified with mass 
spectrometry (Ultraflex MALDI 
TOF/TOF, Bruker Daltonics) by Åke 
Engström at the department of medical 
biochemistry and microbiology, 
Biomedical centre, Uppsala, Sweden. 
 
Crystallization experiments 
Pure wild type Endo-T sample, expressed 
by Genencor® and purified by I. Stals at 
the University of Gent, Belgium, at a 
concentration of 16.5 mg/ml, was used for 
Endo-T wild type enzyme crystallization. 
Two different Endo-T ligand samples were 
prepared as described above (“Ligand 
preparation and analysis”) containing N-
glycans or glycoaspargines at unknown 
concentrations. The Endo-T crystallization 
experiments were performed as described 
by former master student Jing Zhang36. 
Crystallization trials were set up using 
EasyXtal Tool crystallization plates 
(Qiagen, USA) and the hanging drop vapor 
diffusion method. Zink-free and low pH 
crystallization conditions at 20ºC with 8.3 
mg/ml Endo-T, 0.1M Citric acid pH 2.4-
3.0 and the precipitant Polyethylene glycol 
(PEG) 3350 (4-14%) or the precipitant 
mixture PEG 1500/PEG 8000 (4-14% of 
each PEG) were used to crystallize Endo-
T. The oligomannosidic N-glycan and 
glycoaspargine ligands were both co-
crystallized with the Endo-T solution 
and/or soaked into Endo-T crystals 
preceding freezing the crystals in liquid 
nitrogen. The co-crystallization with either 
of the ligands was performed by initially 
drying 1-2 µl highly concentrated ligand 
solution on the crystallization plate lids 
and subsequently placing the 
crystallization solution drop with Endo-T 
on top of the dried ligand. The soaking of 
Endo-T with either of the ligands was 
performed by initially drying 1-2 µl highly 
concentrated ligand solution on 
crystallization plate lids and subsequently 
placing crystallization solution on top of 
the dried ligands where protein crystals 
were later transferred during the crystal 
freezing procedure. Another approach used 
for soaking of Endo-T crystals was placing 
the cryoprotectant solution drop on top of 
the dried ligand which was subsequently 
used in the crystal freezing procedure. 
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Crystal soaking, dehydration & freezing 
The cryoprotectant (cryo) solution used 
prior to the instant freezing of all the Endo-
T crystals, to dehydrate the outside of the 
protein and prevent crystal-damaging ice-
formation, contained 0.1M Citric acid (pH 
2.9), 10% glycerol and 35% PEG3350. 
Some crystals were soaked initially in a 
drop containing mother-well crystallization 
solution and an expected high 
concentration of ligand for about 30 min or 
24 hours before being dipped into cryo 
solution and plunched into liquid nitrogen 
where the crystals were flash frozen 
together with the supporting loop. Other 
crystals were soaked in the cryo solution 
drop containing an expected high 
concentration of ligand for about 30-60 
min before being plunch frozen in liquid 
nitrogen. The crystals were repeatedly 
microscopically checked for damage 
during transportation, soaking and 
dehydration procedures. 
 
Crystal data collection and process 
The X-ray diffraction data sets from the 
protein crystals were obtained by the use of 
the high intensity X-ray providing 
synchrotron, beamline I911-2 at the 
Swedish synchrotron radiation laboratory 
MAX-lab at Lund University, Sweden. An 
X-ray source located at the home lab 
(Dept. of Molecular Biology, Swedish 
University of Agricultural Sciences, 
Uppsala, Sweden) equipped with a rotating 
anode generator (Rigaku Rotaflex 
RTP300) and a Mar345 IP detector, was 
also used for minor X-ray diffraction 
experiments. The collected X-ray 
diffraction data sets were integrated with 
iMosflm 1.0.0 46. Subsequent data 
processing was performed using the CCP4 
program suit47.  
 
 
 
   
Figure 4. HPAEC-PAD analysis of the purification of oligomannosidic N-glycans and glycoaspargines. 
Chromatograms of samples containing different fractions collected during the purification of oligomannosidic N-
glycans (Figure 3A-C) and glycoaspargines (Figure 3D-F) with the carbograph column (AlltechTM Extract 
CleanTM SPE Carbo 150mg/4ml) analyzed by high performance an-ion exchange chromatography with pulsed 
amperometric detection (HPAEC-PAD; ICS-3000, Dionex). The collected fractions include load (Figure 3A and 
D), wash (Figure 3B and E) and elution (Figure 3C and F) fractions from both types of oligomannosidic ligands. 
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The data was scaled and merged with 
Scala48, while the structure was solved by 
molecular replacement using the apo-
structure of Endo-T as search model using 
the program Phaser44. Refinement of the 
structural model was performed using 
Refmac 5.5 49 and the structure model 
building and validating freeware program 
Crystallographic Object-Oriented Toolkit, 
or simply Coot50. The protein structure 
model visualizing program PyMOL51 was 
used to envision various elements of the 
enzyme structure in a cartooned format. 
 
Results 
 
Preparation of oligomannosidic N-
glycan and glycoaspargine ligands 
High mannose type N-glycans were 
obtained from the glycoprotein RNase B 
and are natural ligands to Endo-T 
containing between 5-9 mannose 
residues24. The N-glycans were cleaved of 
in two different ways:a) Precise hydrolysis 
of the glycosidic bond between the 
proximal N-acetylglucosamine and the 
aglycone aspargine catalyzed by Peptide-
N4-(acetyl-ß-glucosaminyl)-asparagine 
amidase F (PNGase F) or b) Pronase 
digestion of the whole protein molecule of 
RNase B into single amino acids leaving 
the N-glycans attached to a single 
aspargine residue. As the pronase digestion 
often is incomplete, the amount of amino 
acid residues attached to the N-glycans can 
vary, however they will despite this fact in 
this study be referred to as 
glycoaspargines. The HPAEC-PAD 
chromatogram of the elution-fraction from 
the N-glycans without aspargine (Figure 
4C) displays 5 peaks probably 
corresponding to the 5 N-glycans 
containing 5-9 mannose residues and 3 
early peaks probably corresponding to the 
4.8M acetonitrile used to elute the bound 
N-glycans. 
 
 
 
Figure 5. Analysis of Endo-T expression levels in culture media from Endo-T mutant H. jecorina variants 
(D129A, Q193A and Y195A) and an Endo-T knock out strain. 12% SDS-PAGE analysis of the amounts of 
secreted Endo-T in extracellular culture medium from three differently catalytically mutated Endo-T producing 
H. jecorina clones (D129A, Q193A and Y195A) and an Endo-T knock out strain grown in 300ml liquid 2% 
lactose induction media cultures. The position on the gel approximately corresponding to the size of Endo-T is 
indicated with a red dotted frame. A band at a size corresponding to Endo-T is indicated with red arrow. Lane 1: 
Low molecular weight (LMW) marker; Lane 2: Endo-T D129A H. jecorina culture media; Lane 3: Endo-T 
variant D129A H. jecorina culture media concentrated 20x; Lane 4: Endo-T Q193A H. jecorina culture media; 
Lane 5: Endo-T variant Q193A H. jecorina culture media concentrated 20x; Lane 6: Endo-T Y195A H. jecorina 
culture media; Lane 7: Endo-T variant Y195A H. jecorina culture media concentrated 20x; Lane 8: Endo-T 
Knock out H. jecorina culture media; Lane 9: Endo-T variant Knock out H. jecorina culture media concentrated 
20x; Lane 10: LMW marker. 
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In the chromatograms from the load- and 
wash-fractions (Figure 4A-B), there are 
peaks with the same retention time as the 
probable N-glycans in the elution-fraction 
(Figure 4C) indicating loss of N-glycans in 
these chromatography steps. In the 
HPAEC-PAD chromatogram of the 
elution-fraction from the glycoaspargine 
ligands (Figure 4F) there are as in the 
elution-fraction of the other type of ligand 
(Figure 4C) 5 peaks probably 
corresponding to the glycoaspargines 
containing 5-9 mannose residues and 2 
early big peaks most likely corresponding 
to the 4.8M acetonitrile. In the 
chromatograms from the load- and wash-
fractions (Figure 4D-E) from the 
glycoaspargines there are several peaks 
spanning from the probable acetonitrile 
peaks to the probable glycoaspargine 
peaks. These could correspond to amino 
acids or peptides not precipitated during 
the protein precipitation, still remaining in 
the sample before carbograph purification. 
 
Expression of three mutant H. jecorina 
Endo-T variants (D129A, Q193A and 
Y195A) and the knock out strain 
The Endo-T expression levels were 
analyzed in extracellular culture medium 
from cultures of three H. jecorina Endo-T 
expressing variants (D129A, Q193A and 
Y195A) and an Endo-T knock out strain by 
SDS-PAGE analysis using 12% manually 
produced gels (Figure 5). Endo-T was 
expected to be overexpressed in the Endo-
T mutant transformed H. jecorina clones as 
a lactose-induced promoter was put in 
front of the mutated Endo-T gene sequence 
coded in the transformed DNA molecule. 
However, no band was found at the 
approximate size of Endo-T (pure Endo-T 
sample comparison with degraded LMW 
marker in Figure 6A, Lane 1, 2, 7 and 8,  
 
 
    A                         B 
           
Figure 6. Analysis of Endo-T expression levels in Avicel purified culture media from Endo-T mutant H. 
jecorina variants D129A, Q193A and Y195A. (A) 12% SDS-PAGE analysis of the amounts of Endo-T in 
Avicel purified culture media samples from variant D129A and Q193A Endo-T producing H. jecorina clones. 
Lane 1: Low molecular weight (LMW) marker; Lane 2: Pure Endo-T overexpressed in Pichia pastoris; Lane 3: 
Endo-T variant D129A H. jecorina Avicel purified sample concentrated 30x; Lane 4: Endo-T variant Q193A H. 
jecorina expressed, Avicel purified sample concentrated 30x; Lane 5: Ultrafiltration flowthrough sample; Lane 
6: Endo-T variant Q193A H. jecorina expressed, Avicel purified sample accidentally dried; Lane 7: Pure wild 
type Endo-T purified from H. jecorina diluted 10x; Lane 8: Low molecular weight (LMW) marker. (B) 15% 
SDS-PAGE analysis of the amounts of Endo-T in Avicel purified culture media samples from variants D129A 
and Y195A Endo-T producing H. jecorina clones. Lane 1: Low molecular weight (LMW) marker; Lane 2: 
Endo-T variant D129A H. jecorina expressed, Avicel purified sample concentrated 120x; Lane 3: Endo-T 
variant D129A H. jecorina expressed, Avicel purified sample concentrated 60x; Lane 4: Empty; Lane 5: Endo-T 
variant Y195A H. jecorina expressed, Avicel purified sample concentrated 120x; Lane 6: Endo-T variant Y195A 
H. jecorina expressed, Avicel purified sample concentrated 60x; Lane 7: Empty; Lane 8: Low molecular weight 
(LMW) marker; Lane 9: Pure wild type Endo-T purified from H. jecorina diluted 50x. 
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area indicated by red dotted frame in 
Figure 5) in either of the culture samples 
lanes indicating Endo-T overexpression. 
There was only one single band at a size 
equivalent to the size of Endo, a faint band 
from the Endo-T mutant D129A H. 
jecorina culture medium (Figure 5, Lane 3, 
band indicated with red arrow) but the 
result was not conclusive. 
 
Endo-T purification 
After being harvested and filtered (to get 
rid of fungal mycelia), the culture media 
were purified by adsorbing the cellulases, 
having a cellulose binding module, onto 
Avicel and then pelleting and discarding 
the Avicel with bound protein together. 
Following the enzyme adsorption onto 
Avicel, the different Endo-T mutant 
samples were analyzed with 12% and 15% 
SDS-PAGE gels. A few bands from all 
three Endo-T mutant samples were located 
at sizes spanning from the size of the pure 
Endo-T sample expressed in Pichia 
pastoris to the pure Endo-T sample  
 
 
A 
 
 
B 
 
 
Figure 7. Purification of Endo-T D129A mutant by an-ion exchange chromatography. An-ion exchange 
chromatography purification of Endo-T D129A mutant with a MonoQ 10/100 GL column (GE Healthcare) in 
20mM Bis-Tris (pH 6.5) buffer and eluted with a linear gradient of 1M NaCl. Samples were collected in 2.5 ml 
fractions. (A) Chromatogram of collected MonoQ-purified fractions (red) showing protein absorbance at 280nm 
(blue) and linear 0-1M NaCl gradient (green). The 3rd peak corresponding to Endo-T is highlighted with a red 
dotted frame (B) 15% SDS-PAGE analysis of MonoQ-separated peak fractions. Endo-T bands are highlighted by 
a red dotted frame. Lane 1: Low molecular weight (LMW) marker; Lane 2: Empty; Lane 3: Pure wild type 
Endo-T purified from H. jecorina diluted 50x; Lane 4: Endo-T variant D129A H. jecorina expressed, Avicel 
purified sample concentrated 60x; Lane 5: Empty; Lane 6: Rescued sample from unsuccessful MonoQ 
separation with 20mM NaAc (pH 5.0) buffer; Lane 7: MonoQ fraction tube 6 from 1st peak; Lane 8: MonoQ 
fraction tube 25 from 2nd peak; Lane 9: Empty (well contamination from lane 8); Lane 10: MonoQ fraction tube 
40 from 3rd peak: 
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expressed in H. jecorina (Figure 6A and 
6B). These gel bands from Endo-T mutant 
D129A and Y195A samples (Figure 6B, 
bands inside the red dotted frame) were 
analyzed by mass spectrometry and one 
analyzed band from the Endo-T mutant 
D129A sample was identified as being 
Endo-T (data not shown). After verifying 
the presence of Endo-T in one of the 
samples, an an-ion exchange 
chromatography purification step with a 
MonoQ 10/100 GL column (GE 
Healthcare) was utilized to purify the 
deglycosylating protein. Three major peaks 
were acquired, one unbound fraction (1st 
peak), one loosely bound fraction (2nd 
peak) and one strongly bound fraction (3rd 
peak) (Figure 7A). A top peak fraction 
from all the peaks was analyzed by 15% 
SDS-PAGE (Figure 7B). A strong Endo-T 
band was found in the sample from the 3rd 
peak (Figure 7B, lane 10) and a faint Endo-
T band was seen in the unbound fraction 
sample from the 1st peak (Figure 7B, lane 
7). The third peak was therefore collected 
and used for further purification. 
 
The Avicel and MonoQ-purified Endo-T 
D129A mutant sample was subsequently  
 
 
A 
 
 
B 
 
Figure 8. Purification of Endo-T D129A variant by size exclusion chromatography. Size exclusion 
chromatography of Endo-T D129A variant with a HiLoad 16/60 Superdex 200 column (GE Healthcare) in 
20mM NaAc (pH 5.0) buffer. Samples were collected in 1 ml fractions. (A) Chromatogram of collected 
Superdex 200-purified fractions (red) showing protein absorbance at 280nm (blue). Collected peak fractions are 
highlighted with a dotted red frame. (B) 15% SDS-PAGE analysis of elution fractions from the Superdex 200 
separated peak. Endo-T bands are highlighted with a red dotted frame. Lane 1: Low molecular weight (LMW) 
marker; Lane 2: Pure wild type Endo-T purified from H. jecorina diluted 100x; Lane 3: Endo-T variant D129A 
H. jecorina expressed, Avicel purified sample concentrated 60x; Lane 4: Pooled Superdex 200 peak fractions 47-
59 concentrated 4x; Lane 5-7: Empty; Lane 8: Pooled Superdex 200 peak fractions 47-59 concentrated 4x; Lane 
9: Low molecular weight (LMW) marker.  
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further purified by size exclusion 
chromatography using a HiLoad 16/60 
Superdex 200 (GE Healthcare) column. A 
double peak (Figure 8A) was obtained 
where the last major part of the peak (peak 
fraction 47-59) was analyzed by 15% SDS-
PAGE (Figure 8B, lane 4 and 8) which 
demonstrated the existence of 3 strong 
separate bands. Two of the bands were 
present at the size of Endo-T while the 
third band was present at a larger size. The 
two bands present at a smaller size were 
analyzed by mass spectrometry and both of 
these bands matched the spectra of the wild 
type Endo-T (data not shown). 
 
Endo-T crystallization 
Endo-T was co-crystallized and/or soaked 
with N-glycans and glycoaspargines, 
natural ligands to Endo-T24, to produce 
ligand bound Endo-T crystals. The 
crystallization experiments were performed 
at low pH (2.4-3.0) in an attempt to 
inactivate the catalytic activity of Endo-T 
and thus avoid hydrolysis of the ligand 
when bound to Endo-T in the crystal 
structure. Many different crystallization 
conditions were found to successfully give 
rise to Endo-T crystals and two optimal 
conditions for Endo-T crystal growth were 
found from which crystals were used for 
X-ray diffraction data collection: 1) 8.3 
mg/ml Endo-T mixed with equal amounts 
of 0.1M Citric acid pH 2.4-3.0 and 4-6% 
PEG 3350; and 2) 8.3 mg/ml Endo-T 
mixed with equal amounts of 0.1M Citric 
acid pH 2.4-3.0, 4-6% PEG 1500 and 4-6% 
PEG 8000. The crystals grown in these 
conditions, both without and co-
crystallized with ligand, displayed mixed 
morphology. The crystal shapes spanned 
from rod structures to cubic and bar 
structures both big and small (Figure 9).  
 
X-ray diffraction and processing 
X-ray diffraction data sets from Endo-T 
were collected at the Swedish synchrotron 
radiation laboratory Max-lab at Lund 
University, Lund, Sweden. Data were 
successfully collected from 5 Endo-T-
crystals grown and soaked at 3 different 
conditions: I) Co-crystallization with 2 µl 
dried oligomannosidic N-glycans 
(unknown concentration) in 0.1M Citric 
acid pH 2.4 and 4-6% PEG3350 
cryoprotected in cryo containing 1 µl dried 
oligomannosidic N-glycans (unknown 
concentration), II) Co-crystallization with 
1 µl dried oligomannosidic 
glycoaspargines (unknown concentration) 
 
 
      A                  B 
                    
Figure 9. Endo-T crystallization. 8.3 mg/ml pure Endo-T sample were crystallized by the hanging drop vapor 
diffusion method mixing equal amounts of 0.1M Citric acid pH 2.4-3.0 and 4-6% of different PEGs. (A) Endo-T 
crystals grown with 0.1M Citric acid pH 2.8 and 6% PEG 3350. Crystals emerged after a week. (B) Endo-T 
crystals grown with 0.1M Citric acid pH 2.4, 4% PEG 1500 and 4% PEG 8000 and co-crystallized with 1ul dried 
oligomannosidic N-glycans of unknown concentration. Crystals emerged after 24 hours. 
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in 0.1M Citric acid pH 2.4, 4-6% PEG1500 
and 4-6% PEG8000 cryoprotected in cryo 
containing 2 µl dried oligomannosidic 
glycoaspargines (unknown concentration) 
and III) Crystallization in 0.1M Citric acid  
pH 2.8 and 6% PEG3350 soaked in cryo 
containing 2 µl dried oligomannosidic 
glycoaspargines (unknown concentration) 
for about 30 min. Clear electron density 
was observed for a bound ligand in every 
co-crystallized Endo T-ligand complex 
structure that was solved. The data that 
resulted into the best structure model was 
obtained from a crystal grown and soaked 
according to the first conditions. The 
structure has been refined to 1.65Å 
resolution with a final R- and Rfree value of 
0.1871 and 0.2142, respectively.  
 
The ligand that was found bound in the 
active site of Endo-T consists of a 
processed and incomplete oligomannosidic 
N-glycan Manα1-6(Manα1-3)Manα1-
6Manβ1-4GlcNAc with missing electron 
density from the pentasaccharide core C3 
linked oligomannosidic branch (Figure 10). 
The overall structure of the crystallized 
Endo-T is an (β/α)8-barrel fold with eight 
β-strand/loop/α-helix units where the 
catalytic site is positioned on top of the 
core of the barrel-structure (Figure 11). 
Two single N-acetylglucosamine units are 
found bound to the protein in the structure, 
one bound to Asn70 and the other to 
Asn240. The introduced ligand is found 
bound in the substrate binding cleft at the 
top of the β-barrel. The distal glycone part 
of the N-glycan is bound over the shallow 
loop of (β/α)8-barrel unit 2, while the 
proximal N-acetylglucosamine is found in 
the center on top of the core of the β-barrel 
at the catalytic site near the catalytic 
residues Asp129 and Glu131 and the 
stabilizing residues Tyr195 and Trp259 
(Figure 12). The distance between the 
outer carbon of the side chain of Glu131 
and the anomeric carbon of the hydrolyzed 
N-acetylglucosamine is 6.88Å (Figure 12). 
Electron density which appear to 
correspond to a furanose ring was found in 
a close approximate to the bound ligand on 
top of the shallow barrel loop unit 8 
(Figure 10 and 14). 
 
 
 
Figure 10. Electron density maps for a (GlcNac)-
Man4 and an unidentified molecule. Cartoon 
visualization of the substrate electron density map 
(marine blue; sigma level 1) fitted with Manα1-
6(Manα1-3)Manα1-6Manβ1-4GlcNAc (red) and an 
unidentified furanose shaped electron density map 
(green; sigma level 1). 
 
 
Discussion 
 
Until just recently there was no knowledge 
about eukaryote ENGase activity among 
the glycoside hydrolases of family 18 
(GH18)16. A peculiar amount of single N-
acetylglucosamine residues, found on N-
glycosylation sites of H. jecorina-secreted 
cellulases, prompted the idea of the 
existence of endo-β-N-
acetylglucosaminidase activity in this 
ascomycete37-41. The hypothesis led to the 
discovery of a fungal Endo-β-N-
acetylglucosaminidase, with the chitinase 
active site motif of the ENGases of 
glycoside hydrolase family 18, named 
Endo-T after the former name of the 
fungus which the enzyme originates, 
Trichoderma reesei24. Simultaneously, on 
the other side of the planet, another Endo-
β-N-acetylglucosaminidase was found 
expressed by a basidiomycete, Flammulina 
velutipes, named Endo-FV. In these 
studies, several additional species of 
ascomycetes and basidiomycetes were also 
found to encompass this activity24, 25.  
20 
 
 
A   B 
  
Figure 11. Endo-T with bound processed substrate (GlcNac)-Man4. Cartoon visualization of Endo-T 
(rainbow colored carbon backbone from blue at the N-terminous to red at the C-terminous of the protein) with a 
bound (GlcNac)-Man4 (blue/red). Two bound single N-acetylglucosamines are shown linked to Asn70 and 
Asn240 (blue). Furanose-shaped electron density is shown in green. (A) Top view of the (β/α)8-barrel structure 
fold with the substrate bound on top of the central β-barrel. (B) Side view of the (β/α)8-barrel structure fold with 
the substrate bound on top of the central β-barrel. 
 
 
Except the urge to learn and understand 
more about the action of these enzymes 
there is also a practical demand for this 
type of activity. The usage of Endo-H 
found to be secreted by Streptomyces 
plicatus is vast in the field of 
glycoproteomics and also X-ray 
crystallography21, 26, 27. The high-price of 
the enzyme has led to the idea of using 
Endo-T as a competing alternative to 
Endo-H usage as it comprise similar 
substrate specificities. As of now, a great 
deal has been elucidated about the enzyme, 
but there are still a lot left to be 
investigated, such as the activating 
mechanisms of N- and C-terminal 
processing24, possible existence of 
transglycosylation properties and the 
mechanisms behind the substrate 
specificity. The latter was the driving force 
behind this study where the goal was to 
introduce a ligand in the active site of 
crystallized Endo-T under such 
circumstances that it would not be 
processed and/or released to enable 
structure determination of Endo-T with its 
natural substrate  bound in the active site, 
unprocessed. To render this possible, two 
angles of attack were chosen. The first one, 
where the key-amino acids, involved in the 
catalytic activity, were replaced by inactive 
alanine residues and the second one, where 
extreme environmental conditions in the 
form of extreme pH were used to disturb 
the energy balances in the different steps of 
the catalytic reaction. The first approach 
was unfortunately derailed during the 
bioengineering of highly Endo-T-mutant 
expressing H. jecorina clones due to 
miscommunications and only one low-
expressing variant were acquired resulting 
in a low concentration sample of mutant 
Endo-T with rather poor purity. The other 
approach was partially successful, yielding 
Endo-T structures with the substrate bound 
in the active site. However, the substrate 
was processed and without adequate 
electron density information about several 
mannose residues in the distal part of the 
oligomannosidic N-glycan, including the 
whole oligomannosidic branch linked to 
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C3 in one of the pentasaccharide mannose 
residues (Figure 10). 
 
Substrate binding interactions with 
Endo-T 
Endo-T binds its substrate (usually 
attached to proteins) with the top of the 
(β/α)8-barrel (indicated by the upward 
direction of the β-barrel β-sheets) parallel 
to the substrate glycans chain (Figure 
11B). The different parts of the N-glycan 
are nicely fitted into low energy pockets 
(Figure 13). The tight and high loops of 
unit 6 and 7 leads to the conclusion that the 
substrate linked aglycone docks above loop 
unit 5 where the side chains of the amino 
acids are pointed down or parallel to the 
(β/α)8-barrel top plain (Figure 11B and 
13B). Hydrophobic residues Leu171 of 
unit 5 and Phe198 of unit 6 are positioned 
at the probable docking area of the 
aglycone and are probably stabilizing the 
Endo-T-aglycone interaction (Figure 13, 
indicated by black). The proposed catalytic 
amino acid residues are positioned in the 
area beneath the N-acetylglucosamine of 
the bound substrate (Figure 12 and 13(pink 
residues)). The proposed stabilizing 
residues Tyr195 and Trp259 are indeed 
located around the N-acetyl arm of the N-
acetylglucosamine and seem to stabilize 
the substrate-Endo-T interaction by 
keeping the N-acetyl arm in a hydrophobic 
environment. The proposed catalytic 
residues Asp129 and Glu131 are situated 
9.8 and 6.9 Å beneath the anomeric carbon 
of the substrate N-acetylglucosamine, 
respectively. In a plausible reaction event 
the two N-acetylglucosamines of the 
unprocessed substrate could descend closer 
to these residues to facilitate the hydrolysis 
of the substrate. At the distal glycone part 
of the bound substrate, including four 
mannose residues (up to nine in the 
unprocessed substrate), in the area of loop 
unit 2, the branched carbohydrate structure 
is fitted in a highly specific polar cleft 
demonstrating the substrate specificity of 
Endo-T (Figure 13, indicated by brown). 
These residues of the glycone cleft, 
including mostly aspargine residues 
located on loop units 1 and 2, are to a high 
degree conserved among the ENGases of 
glycoside hydrolases family 18 42. The 
additional mannose residues, extended 
 
 
 
Figure 12. Active site of Endo-T with bound (GlcNac)-Man4. Cartoon visualization of the active site of Endo-
T (grey) with the bound (GlcNac)-Man4 (yellow/red). Catalytic (Asp129 and Glu131) and stabilizing (Tyr195 
and Trp259) residues are highlighted in green. The distance between Glu131 and C1 of the N-acetylglucosamine 
is shown in black (6.88Å). Electron density of furanose is lightly displayed (grey).   
 
22 
 
 
from distal branched structure of the bound 
substrate, would be positioned slightly 
upwards from the (β/α)8-barrel plain and 
reach a position outside of the Endo-T 
structure (visible in figure 13B). The 
missing branch consisting of up to 3 
mannose residues is normally linked to the 
C3 carbon of the N-acetylglucosamine-
linked mannose residue of N-glycans. This 
C3 bond is directed upwards towards free 
space indicating that the oligomannosidic 
branch is not bound or loosely bound by 
Endo-T. This could also explain the loss of 
electron density information for these 
residues as the flexibility results in 
unfocused X-ray scattering.  
 
Unidentified furanose-shaped electron 
density 
After the last refinement, electron density 
appeared next to the bound ligand above a 
cleft formed by loop unit 8 of the enzyme 
(Figure 10, 11, 13 and 14). 
 
 
A 
 
B 
 
Figure 13. Substrate binding cleft of Endo-T with bound (GlcNac)-Man4. Surface representation of the 
binding cleft of Endo-T. The protein residues are rainbow colored (from blue at the N-terminous to red at the C-
terminous) except for the aglycone residue area (black), catalytic residue area (pink) and the distal glycone 
residue area (brown). The substrate (GlcNac)-Man4 is shown bound in the cleft (blue/red). Furanose electron 
density is shown in green. (A) Aglycone entrance view of the binding cleft. (B) Distal glycone view of the 
binding cleft. 
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It has a shape of a furanose ring and fits 
very well in what appears to be a cleft 
intended for substrate binding. As the C3-
branched distal mannose residue of the 
substrate is elongated in the C2 position, 
which is directed in the opposite direction 
to the electron density, the furanose is not 
likely to be part of the distal glycone part 
of the substrate. Hybrid type N-glycans can 
sometimes include an N-acetylglucosamine 
residue linked to C4 of the proximal 
mannose residue of the pentasaccharide 
core. However, N-acetylglucosamine is a 
six-membered pyranose ring and the bond 
of C4 where it is attached is pointing in the 
opposite direction to the electron density5. 
There are four polar amino acids within a 
distance of 4Å from the furanose density, 
including two glutamic acids (Glu229 and 
Glu260), a glutamine (Gln14) and a 
threonine (Thr15), which creates a positive 
environment for a bound carbohydrate 
residue. The stabilizing residue, Trp259 is 
also located within 3Å underneath the 
furanose density. All in all an oddly well 
constructed carbohydrate-friendly polar 
cleft with some unidentified molecule 
bound to it. 
 
Structural comparison between Endo-T 
and GH18 homologues Endo-H and 
Endo-F3 
The sequence identity between Endo-T and 
its (β/α)8-barrel folded glycoside family 18 
homologues Endo-H from Streptomyces 
plicatus21 and Endo-F3 from 
Elizabethkingia meningoseptica22 is low. 
This fact is demonstrated by the highly 
dissimilar structures of the (β/α)8-barrel 
loops. A short glimpse of the family 
member proteins superimposed will also 
reveal differences in α-helix arrangements 
(Figure 15). The similarities are instead 
found in the residues involved in the 
substrate-protein interactions. The amino 
acids involved in substrate recognition and 
hydrolysis are in most cases conserved 
within the ENGases of GH18.
 
 
 
Figure 14. Furanose-shaped electron density at the active site of Endo-T. Cartoon visualization of the 
environment around a furanose-shaped electron density (marine blue). Catalytic residues (green/red), residues in 
the area of the furanose-shaped density (yellow/red) and the (GlcNac)-Man4 ligand (red) are highlighted in the 
visualization. Two bound N-acetylglucosamines are shown linked to Asn70 and Asn240 (blue).  
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Endo-H has similar substrate specificities 
as Endo-T as both enzymes hydrolyze 
high-mannose type N-glycans and are 
unable to process complex type N-
glycans21, 24 while Endo-F3 hydrolyze bi- 
and triantennary complex-N-glycans22. The 
loop regions in unit 5 and 6, where the 
aglycone protein docks, demonstrate some 
differences between the homologues. 
Endo-H has very short and low loop 
regions and misses the two α-helixes of 
unit 5 and 6 while Endo-T and Endo-F3 
possess larger and longer loops and 
encompass both helixes of unit 5 and 6. 
The loop units 5 and 6 of Endo-F3 are 
relatively long, creating steric hindrance to 
larger glycoproteins causing it to be less 
effective against these macromolecules30. 
Endo-T is something in between but is 
surely somewhat affected by loop units 5 
and 6 during the docking of glycoproteins. 
Endo-H, on the other hand, is together with 
its structure homologue Endo-F122, 43, 
probably two of the most effective 
ENGases against large glycoproteins 
because of their shallow and flexible barrel 
units 5 and 642. The catalytic aspartic acid 
and glutamic acid are conserved in all three 
homologues attached in the border between 
the β-sheet and loop of unit 4 but with 
some different positioning (not shown). 
The aspartic acids (Endo-T: Asp129, 
Endo-H: Asp 130, Endo-F3: Asp126) of 
the homologues are very similar in 
position, located within 1.4Å of each other 
when these structures are superimposed. 
The glutamic acids are slightly more 
segregated (Endo-T: Glu131, Endo-H: 
Glu132, Endo-F3: Glu128), where Endo-H 
is 1.8Å closer to the center of the active 
site compared to the other two which are 
very similarly positioned. These 
differences are small but the change of 
1.8Å in glutamic acid positioning in Endo-
H could result in more effective hydrolysis 
of substrates. Finally, the distal glycone 
area around loop unit 2, where there are 
differences. Endo-T and Endo-H have a 
very similar loop structures except for the 
fact that loop unit 2 of Endo-H includes 
anti-parallel β-sheets. These loops are long 
but very low in comparison to loop unit 2 
of Endo-F3 which is compact and creates a 
high wall. This is demonstrated by the 
substrate specificity of Endo-F3 where the 
natural biantennary substrate is bound with
 
A               B 
   
Figure 15. Structural comparison with homologue proteins of GH18. Cartoon visualization of Endo-T (blue) 
superimposed with (A) Endo-H (green; PDB code: 1EDT) from Streptomyces plicatus and (B) Endo-F3 (yellow; 
PDB code: 1EOM) from Elizabethkingia meningoseptica. The (GlcNac)-Man4 ligand is shown in red together 
with the furanose electron density (yellow and green, respectively). 
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the distal part of the N-glycan directed 
upwards from the (β/α)8-barrel into free 
space and not along the top of the (β/α)8-
barrel across unit 2 as for Endo-T and 
probably Endo-H. 
 
Substrate binding comparison between a 
substrate from Endo-F3 and the bound 
substrate of Endo-T 
An Endo-F3 structure with a biantennary 
complex N-glycan ligand bound in the 
active site (PDB code: 1EOM) was 
superimposed with Endo-T with the bound 
oligomannosidic N-glycan. The protein 
part of the Endo-F3 ligand complex was 
then removed to compare the positions of 
the two ligands in Endo-T (Figure 16). The 
anomeric carbon of the proximal N-
acetylglucosamine of the complex type 
ligand at the active site was about 2.5Å 
closer to the catalytic residue, Glu131, 
compared to the distance between the 
anomeric carbon of the proximal N-
acetylglucosamine of the oligomannosidic 
ligand and Glu131. As previously 
mentioned (see “Substrate binding 
interactions with Endo-T”) the two 
proximal N-acetylglucosamine residues of 
the unprocessed high-mannose type N-
glycan might descend closer to Glu131 
during hydrolysis thereby enabling the 
reaction. The distal glycone part of the two 
substrates also display some differences, 
where the complex type substrate is wider 
and therefore takes up more space in the 
binding cleft. However, because of its 
distal direction upwards from the (β/α)8-
barrel and into free space, it is not affected 
by the loop region around unit 2 as for the 
substrate of Endo-T. The positioning, and 
in this case the tilt, of the substrates can 
therefore explain the substrate specificities 
of the different homologue ENGases of 
glycoside hydrolases family 18.  
 
Concluding remarks 
A structure of Endo-β-N-
acetylglucosaminidase-T was solved with a 
processed (GlcNac)-Man4 bound at the 
active site of a fully catalytically 
competent wild type enzyme, by extreme
 
 
 
Figure 16. Active site of Endo-T with bound (GlcNac)-Man4 and superpositioned Endo-F3 biantennary 
octasaccharide ligand. Cartoon visualization of the active site of Endo-T (grey) with a bound (GlcNac)-Man4 
(red) superimposed with the Endo-F3 active site-positioned biantennary octasaccharide ligand (yellow; PDB 
code: 1EOM). Catalytic (Asp129 and Glu131) and stabilizing (Tyr195 and Trp259) residues together with 
furanose electron density is shown in green.   
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pH-inactivation. The anomeric carbon of 
the proximal N-acetylglucosamine of the 
substrate was positioned 6.88Å from the 
suggested catalytic amino acid residue 
Glu131, indicating a descending motion of 
the two N-acetylglucosamines of the 
unprocessed oligomannosidic N-glycan 
substrate during hydrolysis. The distal part 
of the glycone was precisely fitted in a 
polar cleft of mostly aspargines around 
loop unit 2. The position of the proximal 
part of the substrate and the loop-structure 
of Endo-T suggests aglycone docking 
centered over (β/α)8-barrel unit 5. Future 
prospects include further inactivation of 
Endo-T by lowering the pH or by site-
directed mutagenesis on catalytic amino 
acid residues. An engineered N-glycan 
substrate has also been produced that can 
not be hydrolyzed by Endo-T and will 
therefore bind in the active site of Endo-T 
and stay there through crystallization and 
freezing processes. The result will be un-
hydrolyzed substrates bound in the active 
site supplying information about both 
aglycone and glycone interactions with 
Endo-T. Some method must also be 
proposed for stabilizing the distal 
oligomannosidic part of the N-glycan 
substrates when bound in Endo-T crystals 
to enable the collection of electron density 
information about these glycan residues. 
Exploration of these interactions between 
ENGases and their substrates will 
enlighten the purpose for the existence of 
these carbohydrate active enzymes and 
facilitate the manufacturing of 
programmed glycoside hydrolases, built 
for a purpose in different fields, such as 
biomass conversion or glycotherpeutics. 
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